Anheuser-Busch InBev SA/NVBUD
NYSE • Consumer Defensive
$80.02
P/E
13.10
PEG
—
FCF Yield
—
Rev Growth YoY
-49.2% YoY
Gross Margin
56.6%
Health Score
7/10
D/E Ratio
0.84
Confidence
—
Business Snapshot
Anheuser-Busch InBev is the world’s largest brewer, with a portfolio of global brands including Budweiser, Stella Artois, and Corona. It operates in the alcoholic beverages industry and holds a dominant competitive position across both developed and emerging markets. The company is a mega-cap with $105.04B in trailing twelve-month revenue, reflecting its massive scale and distribution infrastructure. Its defining characteristic is the combination of a vast global distribution network and an iconic brand portfolio, creating a durable competitive moat.
Financial Health
Gross margin improved slightly to 56.6% from 56.3% in the prior year, while net margin stands at 11.9%. The debt/equity ratio of 0.84x is manageable, but the current ratio of 0.72x points to potential short-term liquidity pressure...
Risk Assessment
- REVENUE DECELERATION — Revenue fell 49.2% YoY and 49.1% QoQ, indicating a sharp and ongoing contraction in top-line performance.
- LIQUIDITY — Current ratio of 0.72x is below 1.0x, suggesting potential difficulty covering short-term obligations.
- EARNINGS QUALITY — Despite four consecutive earnings beats, the massive revenue decline raises questions about the sustainability of earnings levels.
- VALUATION DIVERGENCE — The FMP DCF suggests a discount, but the Python DCF was not calculable, creating uncertainty in the intrinsic value estimate.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed....